CD20 MicroBeads were developed for positive selection or depletion of human CD20+ B cells from different cell sources such as human PBMCs, bone marrow, cell cultures or lymphoid tissues.
Related products for CD20 MicroBeads, human
CD20 MicroBeads were developed for positive selection or depletion of human CD20+ B cells from different cell sources such as human PBMCs, bone marrow, cell cultures or lymphoid tissues.
CD20 is a non-glycosylated transmembrane protein of 33–37 kDa that becomes heavily phosphorylated upon activation1,2. It is expressed exclusively on B cells, including pre-B cells, naive, mature, and activated B cells, B cell blasts, and the majority of malignant B cells, but not on early B cell progenitors or plasma cells2,3.
Purified CD20+ B cells may be used in cell biological studies, such as analysis of signal transduction, chemotaxis, allergen response, apoptosis, or in molecular studies, e.g., subset-specific microarrays.
For positive selection: MS, LS, XS, or autoMACS® Columns. For depletion: LD, D, or autoMACS Columns.
B cells were separated from PBMCs using CD20 MicroBeads and the autoMACS™ Separator.
- Chang et al. (1996) Appl. Immunohistochem. 4: 1-15
- Cragg, M. S. et al. (2002) Opposing properties of CD20 mAb. In: Leucocyte typing VII, Oxford University Press.
- Polyak et al. (2002) CD20 Workshop Panel report. In: Leucocyte typing VII, Oxford University Press.
- Countouriotis, A. et al. (2002) Cell surface antigen and molecular targeting in the treatment of hematologic malignancies. Stem Cells 20: 215-229